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Introduction {#sec1}
============

Lineage-specific differentiation protocols from either human embryonic stem cells (hESCs) or human induced pluripotent stem cells (hiPSCs) toward the keratinocyte lineage represent a useful tool to generate human skin tissue ([@bib13], [@bib14], [@bib18], [@bib19], [@bib25], [@bib38]). Several applications can be found for these protocols, such as investigating the molecular mechanisms involved during the development of this cell lineage or *in vitro* modeling of skin diseases. Indeed, many iPSC-based models have already been reported for several tissues including brain, heart, blood, and skin ([@bib6], [@bib11], [@bib21], [@bib22], [@bib26], [@bib30]).

Current protocols on skin epithelial differentiation require the use of specific culture conditions as well as different coating or supportive feeder layers. They also need to be reproducible, robust, and efficient enough to deliver high amounts of pure differentiated cells, especially if the future goal is a clinical application. In addition, these protocols should be validated by functional assays, for example, grafting hiPSC-generated keratinocytes on organotypic cultures to prove their ability to build a whole stratified epithelium ([@bib1], [@bib8], [@bib14], [@bib18]). Nevertheless, the efficiency to establish not only a pure keratinocyte population from PSCs but also skin epithelial precursors remains poor to date, one of the reasons being the lack of knowledge of the molecular mechanisms regulating the early steps of the epithelial/ectodermal commitment.

Large-scale loss-of-function (RNAi) screening offers a systematic genetic approach to study lineage-specific differentiation mechanisms. To identify key actors of the epithelial/ectodermal commitment, we performed a kinome RNAi screen targeting a total of 719 kinases, followed by differentiation lasting 10 days ([@bib10]). We then used a live-cell assay and automatic microscopy based on keratin 18 (K18) expression to monitor the amount of generated epithelial cells. We identified 62 activators and 36 inhibitors of this differentiation, among which the homeodomain interacting protein kinase 4 (HIPK4) was validated as a novel negative regulator.

Results {#sec2}
=======

Characterization of Human Skin Epithelial Cells {#sec2.1}
-----------------------------------------------

hiPSCs were generated in our laboratory from fibroblasts of healthy donors ([@bib22]) and were differentiated for 5 days, 10 days, and 30 days toward the skin epithelial lineage by maintaining them in defined keratinocyte serum-free medium (DKSFM) containing retinoic acid (RA) (1 μM) and bone morphogenetic protein 4 (BMP4) (10 ng/mL), according to the protocol of [@bib18] ([Figure 1](#fig1){ref-type="fig"}A). Gene expression profiling of the differentiated cells at day 5 and day 10 showed an increased expression of ectodermal, epithelial, and epidermal gene signatures compared with day 0 (hiPSCs) ([Figure 1](#fig1){ref-type="fig"}B). In particular, day-10 differentiated cells showed increased expression of several collagens, integrins, keratins, and laminins. Moreover, the pluripotency gene signature (including *SOX2*, *OCT4*, and *NANOG*) was downregulated and gene signatures of undesired lineages such as neuroectoderm, endoderm, or mesoderm were either not expressed or even downregulated compared with day 0 ([Table S1](#mmc1){ref-type="supplementary-material"}). These data were then confirmed by qPCR for some of the ectodermal/epithelial markers: *BMP4*, *BNC1*, *GATA2*, *FZD6*, and *AP2A* were all upregulated at day 5 and day 10 compared with day 0 ([Figure 1](#fig1){ref-type="fig"}C, top panel). Conversely, mesodermal marker (*KDR*), endodermal markers (*GATA4*, *AFP*, *UPK1B*, and *FOXA2*) and neuroectodermal markers (*PAX6*, *PARP1*, and *FGF2*) were expressed at very low levels compared with day 0 ([Figure 1](#fig1){ref-type="fig"}C, bottom panel).Figure 1Characterization of Human Skin Epithelial Cells(A) Schematic of the skin epithelial differentiation protocol.(B) Microarray-based log~2~-expression of known gene signatures associated with ectodermal development, and epithelial and epidermal differentiation at day 0, day 5, and day 10 of differentiation. Statistical analysis was performed using a two-tailed paired Student\'s t test (^∗∗^p \< 0.001, ^∗∗∗^p \< 0.0001).(C) Top panel: qPCR analysis of *BMP4* (ectodermal/epithelial marker), *BNC1* (ectodermal/epidermal marker), *GATA2* (ectodermal marker), *FZD6*, and *AP2A* (epithelial markers), at day 0, day 5, and day 10 of differentiation. Bottom panel: qPCR analysis of mesodermal marker (*KDR*), endodermal markers (*GATA4*, *AFP*, *UPK1B*, and *FOXA2*), and neuroectodermal markers (*PAX6*, *PARP1*, and *FGF2*).(D) qPCR analysis of keratin 8 (*K8*), keratin 18 (*K18*), keratin 5 (*K5*), keratin 14 (*K14*), and *p63* expression at day 0, day 5, day 10, and day 30 of differentiation. Normal human keratinocytes (NHK) were used as control. n.d., not detectable.(E) Immunofluorescence staining against K18, K14 and p63 at day 10 and day 30 of differentiation. Histogram represents the percentage of positive cells.Data in (B) to (E) represent a mean of three independent experiments ± SEM.

Furthermore, the differentiation at day 30 showed a cell phenotype and a gene expression profile closely resembling that of normal human keratinocytes (NHK). Indeed, a hierarchical clustering representation of the samples showed that cells differentiated at day 5, day 10, and day 30 presented closer similarities to NHK than at day 0 ([Figure S1](#mmc1){ref-type="supplementary-material"}A). This suggests that cells were already committed to an epithelial identity as early as day 5 of differentiation. Additionally, we confirmed by qPCR at day 5 and day 10 an increased expression of epithelial markers such as keratin 8 (*K8*) and *K18*, expression of which then decreased at day 30 and switched to an increased expression of keratinocyte markers such as keratin 5 (*K5*) and keratin 14 (*K14*). The expression of *p63*, a transcription factor involved in epidermal proliferation and stratification, was upregulated at day 10 and increased at day 30 ([Figure 1](#fig1){ref-type="fig"}D).

Finally, immunostaining of K18 at day 10 (subsequently used to monitor the RNAi screen, see below) presented 40% positive cells compared with 0% in the undifferentiated control condition ([Figures 1](#fig1){ref-type="fig"}E and [S1](#mmc1){ref-type="supplementary-material"}B). As expected, day-10 differentiated cells were also positive for p63 staining (30%) but not for K14, since this marker\'s expression increases later during the differentiation. Indeed, day-30 differentiated cells were positive for K14 (50%) and p63 (50%) staining but no longer for K18 due to its early transient expression.

Together, these data show that our differentiation protocol generates day-5 and day-10 differentiated cells with an ectodermal/skin epithelial identity and generates day 30 differentiated cells presenting a keratinocyte-like phenotype and identity. In the following experiments, we focused on day-10 differentiated cells to investigate the molecular mechanisms that regulate early skin epithelial differentiation.

High-Throughput RNAi Screen Analysis Identifies HIPK4 as an Inhibitor of Skin Epithelial Differentiation {#sec2.2}
--------------------------------------------------------------------------------------------------------

We next performed an RNAi-based screen during early epithelial differentiation to identify key regulators, with the ultimate goal of improving its low efficiency. In brief, hiPSCs were single-cell seeded on Matrigel-coated 384-well plates and transfected directly in the differentiation medium with a kinome RNAi library containing small interfering RNAs (siRNAs) targeting kinases and kinase-regulatory proteins. After 10 days, the cells were stained against K18 and subsequently image processed with an automated microscope ([Figure 2](#fig2){ref-type="fig"}A).Figure 2High-Throughput RNAi Screen Identifies HIPK4 as an Inhibitor of Skin Epithelial Differentiation(A) Schematic of the RNAi screen workflow. Single hiPSCs were reverse transfected with a kinome RNAi library and differentiated into epithelial precursors. At day 10, immunofluorescence staining against K18 was performed and cells were imaged by automated microscopy.(B) Scatterplot of data where each siRNA from the screen at day 10 is represented as the *Z-*score value. Plot includes negative (red, *Z* score = +1.3) and positive (blue, *Z* score = −1) controls. Positive control condition corresponds to cells transfected with *siControl* and differentiated for 10 days. Negative control condition corresponds to cells maintained in pluripotency condition for 10 days. Arrow marks siRNA against *HIPK4* as a sample with increased numbers of K18^+^ cells compared with the positive control.(C) Representative images of K18 immunostaining and quantification of percentage of positive cells after 10 days of differentiation with or without *siHIPK4* or *siADCK2*. Scale bar, 100 μm.

During the screen\'s image analysis, the number of K18^+^ cells was determined, the values normalized per assay plate, and the *Z* scores calculated. [Figure 2](#fig2){ref-type="fig"}B shows the distribution of the control groups by their *Z* score and indicates a clear distinction between the positive control, in which conditions were applied to promote differentiation (cultured with DKSFM containing RA + BMP4) and the negative control, in which conditions were used to maintain pluripotency (cultured with mTeSR medium for 10 days). Two independent screens were performed, and only the results that increased or reduced the percentage of K18^+^ cells from the sample median by at least two median absolute deviations were considered as hits. A gene was considered as a potential regulator of epithelial cells when both replicates were scored as hits.

Out of 232 hits, 35 genes were involved in tissue development functions (such as the fibroblast growth factor receptor \[*FGFR*\] family) as expected for this assay based on stem cells\' early differentiation. We also found *BMPR1B* (bone morphogenetic protein receptor, type IB), a member of the BMP pathway, which supports our epithelial differentiation. BMP targets are indeed known to influence the development, differentiation, and proliferation of the epidermis ([@bib25]), and *BMPR1B* was described to be associated with epidermal differentiation ([@bib5], [@bib27]). In addition, we found genes associated with IKKs (inhibitor of kappa light polypeptide gene enhancer in B cells), such as *IKBKAP* (inhibitor of kappa light polypeptide gene enhancer in B cells, kinase complex-associated protein), which is a regulator of IKKs, and *IKBKE* (inhibitor of kappa light polypeptide gene enhancer in B cells, kinase epsilon) which is a non-canonical IKK. Of note, IKKα can promote epidermal differentiation independently of its nuclear factor κB (NF-κB) function ([@bib16]). Finally, members of the MAPK pathway were also involved in K18 regulation: *MAPK1* (mitogen-activated protein kinase 1), *MAP2K1* to *MAP2K5* (mitogen-activated protein kinase kinase 1--5), *MAP3K3* and *MAP3K12* (mitogen-activated protein kinase kinase kinase 3 and 12). Together, these data support the functional relevance of our screen\'s hit list in the regulation of epithelial differentiation ([Tables S2](#mmc1){ref-type="supplementary-material"} and [S3](#mmc2){ref-type="supplementary-material"}).

Next, genes with a *Z* score lower than the averaged positive controls were identified as inhibitor candidate genes and genes with a higher *Z* score than the averaged negative controls were identified as promoter candidate genes ([Table S4](#mmc1){ref-type="supplementary-material"}). One of the promoter candidate genes was *ADCK2* (AarF domain containing kinase 2), mutation of which is associated with Klippel-Feil syndrome, a disease involving segmentation defects during early development. This gene was used as a representative example of differentiation promoter gene as the K18^+^ cell number remained close to 1% after a differentiation of 10 days ([Figure 2](#fig2){ref-type="fig"}C). On the other hand, one inhibitor candidate gene, *HIPK4*, encodes for a conserved serine/threonine kinase belonging to the HIPK family (homeodomain interacting protein kinase 1--4), which plays a role in a large set of cell functions, including differentiation ([@bib15]). *HIPK4* is described to be expressed in human skin according to the GeneCards online database (<https://genecards.weizmann.ac.il/v3/cgi-bin/carddisp.pl?gene=HIPK4#expression>). Moreover, we observed Hipk4 expression in the skin of mouse embryos, suggesting a potential role for this protein in the early development of the skin ([Figure S2](#mmc1){ref-type="supplementary-material"}A).

Indeed, quantification of K18^+^ cells in *HIPK4* knockdown condition after 10 days of differentiation indicated 85% positive cells compared with 50% in the positive control condition (*siControl*). As expected, no K18 expression was found in the negative control condition (cells maintained in pluripotency condition) ([Figure 2](#fig2){ref-type="fig"}C). Overall, this RNAi screen allowed us to identify several putative regulators of human skin epithelial differentiation, and specifically suggests HIPK4 as a strong inhibitor of this process.

Validation of HIPK4 as an Inhibitor of Skin Epithelial Differentiation {#sec2.3}
----------------------------------------------------------------------

In the next step, we quantified by immunostaining the number of cells positive for K18, K14, and p63 at day 10 and day 30 of differentiation ([Figures 3](#fig3){ref-type="fig"}A and [S2](#mmc1){ref-type="supplementary-material"}B). At day 10, *HIPK4* silencing induced an increase of K18^+^ cells (80%) compared with the *siControl* condition (40%). As expected at this time point, no K14^+^ cells were observed. Similarly at day 30, *HIPK4* silencing induced a small but significant increase of K14^+^ cells (65%) compared with the *siControl* condition (50%). Interestingly, at day 10, the number of p63^+^ cells was not affected by *HIPK4* knockdown (around 30%) but increased significantly at day 30 compared with the *siControl* condition (from 50% to 65%). These data suggest that the inhibitory role of HIPK4 on K18 expression before day 10 is independent of p63. At a later time point, however (day 30), the increase in K14^+^ and p63^+^ cells in the *siHIPK4* condition may simply be due to an increased pool of day-10 precursors that matured in keratinocytes.Figure 3Validation of HIPK4 as an Inhibitor of Skin Epithelial Differentiation(A) Immunofluorescence staining against K18, K14, and p63 at day 10 and day 30 of differentiation in control condition and under *HIPK4* knockdown. Histogram represents the percentage of positive cells. Data represent a mean of three independent experiments ± SEM. Statistical analysis was performed using unpaired Student\'s t test (^∗^p \< 0.05). n.d., not detected.(B) qPCR analysis of epithelial markers under *HIPK4* knockdown at day 10 (black bars) and keratinocyte makers under *HIPK4* knockdown at day 30 (gray bars). Values represent fold changes compared with the respective controls and are mean of three independent experiments ± SEM.(C) Western blot analysis of HIPK4 and K18 expression in the indicated conditions.(D) Heatmap representing a hierarchical gene clustering of pluripotency, epidermal, and epithelial markers generated from hiPSCs (d0), normal human keratinocytes (NHK), and day 5 (d5) and day 10 (d10) of differentiation with or without *HIPK4* knockdown. Color code represents log~2~-expression values.(E) Ingenuity Pathway Analysis showing some of the top regulated signaling pathways after *HIPK4* knockdown at day 10 of differentiation (compared with *siControl*).(F) qPCR analysis of *IL-6* and three members of the TGF-β signaling (*TGFB1*, *TGFBR2*, and *CTGF*) under *HIPK4* knockdown at day 10. Data represent a mean of three independent experiments ± SEM.

We also analyzed the expression of epithelial markers at day 10 or keratinocyte markers at day 30 in these samples. In addition to K8 and K18, the expression of *BMP4*, *ZEB2*, *FOXC1*, and *FRZB* was upregulated by at least 2-fold at day 10 under *HIPK4* knockdown compared with the *siControl* condition. Similarly, the expression of *K5*, *K14*, and involucrin (*IVL*) was upregulated by at least 5-fold at day 30 in the *HIPK4* knockdown condition ([Figure 3](#fig3){ref-type="fig"}B). The regulation of K18 expression by HIPK4 was also analyzed by western blot in a kinetic experiment from day 5 to day 10 ([Figure 3](#fig3){ref-type="fig"}C). HIPK4 expression, which starts at day 6 in the control condition, was delayed to day 9 under *HIPK4* silencing. The restoration of HIPK4 expression after day 9 in the knockdown condition was probably due to the combined effects of transient siRNA silencing and increased expression during differentiation. Consequently, K18 expression, which started at day 7 in the control condition, was already expressed at day 6 in the *HIPK4* knockdown condition, and accumulated at day 10 to higher levels than in the control condition.

Because the screen\'s potential off-target effects are to be expected, the differentiation experiment was repeated with two independent *HIPK4* siRNAs. The analysis at day 10 revealed that each single *HIPK4*-specific siRNA led to gene silencing (50% and 40%, respectively). Consistently, the increase in K18 expression under *HIPK4* silencing was still observed ([Figure S3](#mmc1){ref-type="supplementary-material"}A). Moreover, the negative regulation of HIPK4 on K18 expression was reproduced in a second hiPSC line (HD1). At day 5, transfection with *siHIPK4* did not significantly increase K18 expression, likely due to the absence of *HIPK4* at this time point; however, at day 10 *siHIPK4* caused more than a 50% reduction in *HIPK4* expression and a 2-fold increase of K18 expression compared with *siControl* ([Figure S3](#mmc1){ref-type="supplementary-material"}B).

For better characterization of the differentiated cell populations, microarray analysis of transcriptome profiles from control and *HIPK4* knockdown samples at day 5 and day 10 was conducted together with day-0 and NHK samples. To exclude a potential effect of *HIPK4* silencing on other undesired lineage differentiation, we verified that endodermal, mesodermal, and neuroectodermal markers\' expression was minimal under *HIPK4* silencing at day 10 compared with the control ([Figure S3](#mmc1){ref-type="supplementary-material"}C and [Table S5](#mmc1){ref-type="supplementary-material"}). A hierarchical clustering of the samples then gave two main points of information ([Figure S4](#mmc1){ref-type="supplementary-material"}A): (1) *HIPK4* knockdown at day 5 induced no major effect as HIPK4 was still not expressed at this time point ([Figure 3](#fig3){ref-type="fig"}C); and (2) *HIPK4* knockdown at day 10 is clearly distinct from knockdown at day 5. Moreover, we were able to retrieve in a hierarchical gene clustering pluripotency markers, expression of which was high at day 0 and was then reduced during the differentiation process. Conversely, epithelial and epidermal markers were upregulated during the process and to a higher extent under *HIPK4* knockdown than in the control at day 10 ([Figure 3](#fig3){ref-type="fig"}D). As explained above, these markers were not regulated at day 5. Furthermore, principal component analysis showed that differentiated samples were very different from day 0 and NHK samples ([Figure S4](#mmc1){ref-type="supplementary-material"}B).

Finally, we performed a pathway analysis of the top regulated genes under *HIPK4* knockdown at day 10 ([Figure 3](#fig3){ref-type="fig"}E and [Table S6](#mmc3){ref-type="supplementary-material"}). Among the top regulated signaling pathways, we found Wnt/β-catenin, NF-κB, PTEN (phosphatase and tensin homolog), interleukin-6 (IL-6), and transforming growth factor β (TGF-β)/BMP. Interestingly, we were able to confirm by qPCR an upregulation of *IL-6* under *HIPK4* knockdown, as well as an upregulation of one TGF-β receptor (*TGFBR2*), although *TGFB1* and one downstream target *CTGF* were not regulated. These data suggest that IL-6 and TGF-β/BMP signaling may be involved in an HIPK4-dependent mechanism ([Figure 3](#fig3){ref-type="fig"}F).

Together, loss of *HIPK4* during the early steps of epithelial differentiation leads to a significant enrichment in K18^+^ cell number and to an increase in epithelial and epidermal gene signature, confirming a negative role of HIPK4 in this process. In addition, loss of *HIPK4* also leads to an increase in K14^+^ cell number after 30 days of differentiation and to an upregulation of keratinocyte markers. Furthermore, we hypothesize that IL-6 and/or TGF-β signaling could be involved in this mechanism, although this needs to be confirmed by additional investigation.

Loss of HIPK4 Alone Is Not Sufficient to Induce Differentiation but Its Kinase Activity Is Necessary to Upregulate K8/K18 {#sec2.4}
-------------------------------------------------------------------------------------------------------------------------

We then tested the effect of the absence of RA and BMP4 in DKSFM medium on the differentiation. First, in the presence of the cytokines no effect of the knockdown was observed at day 5, but the expression of *HIPK4* at day 10 was reduced by the knockdown and K18 expression was 2-fold upregulated ([Figures 4](#fig4){ref-type="fig"}A and 4B). Interestingly, the cells maintained in DKSFM medium without RA or BMP4 did not undergo differentiation and remained in stem cell colonies ([Figure 4](#fig4){ref-type="fig"}C). qPCR analysis showed that *siHIPK4* had no effect on K18 expression not only at day 5 but also at day 10 compared with the control ([Figure 4](#fig4){ref-type="fig"}D). These results indicate that although *HIPK4* silencing contributes to K18 regulation during early epithelial differentiation, it is not enough to induce differentiation from hiPSCs by itself.Figure 4Loss of HIPK4 Alone Is Not Sufficient to Induce Differentiation but Its Kinase Activity Is Necessary to Upregulate K8/K18(A and C) Bright-field images of cells at day 10 of differentiation in DKSFM medium in the presence (A) or absence (C) of retinoic acid (RA) and bone morphogenetic protein 4 (BMP4) in *siControl* and *siHIPK4* conditions at two different magnifications: top pictures at 20× (scale bar, 600 μm); bottom pictures are a combination of 36 images at 4× (scale bar, 1,000 μm).(B and D) qPCR analysis of *HIPK4* and *K18* in the presence (B) or absence (D) of RA and BMP4 at day 5 and day 10 is presented. Data represent the mean of three independent experiments ± SEM. Statistical analysis was performed using unpaired Student\'s t test (^∗^p \< 0.05).(E) hiPSCs were transduced with an overexpressing vector for wild-type HIPK4 (WT HIPK4 OE) or kinase dead mutant HIPK4 (mutant HIPK4 OE), or with an empty vector, and differentiated for 10 days. RNA expression of *HIPK4*, *K8*, and *K18* is shown. Data represent a mean of three independent experiments ± SEM. Statistical analysis was performed using unpaired Student\'s t test (^∗^p \< 0.05).

To confirm the role of HIPK4 in K18 expression, we overexpressed a wild-type form and a kinase dead mutant of HIPK4 in hiPSCs and differentiated the cells for 10 days. In the control condition, K8 and K18 were upregulated as expected, compared with day 0. Interestingly, the overexpression of wild-type HIPK4 led to a decrease in K8 and K18 expression compared with the control condition ([Figure 4](#fig4){ref-type="fig"}E). Moreover, the overexpression of the mutant HIPK4 (kinase dead) restored the expression of K8 and K18 to levels almost similar to the control condition. These data confirm that HIPK4 functions as a brake to epithelial differentiation, and this involves its kinase activity.

HIPK4 Silencing Promotes the Differentiation of Epithelial Precursors in Organotypic Cultures {#sec2.5}
---------------------------------------------------------------------------------------------

Lastly, we investigated the effect of epithelial precursors in organotypic cultures (OTCs) by evaluating the epithelial growth and morphogenesis. We expected an optimal induction of epithelial differentiation due to the inductive potential of the dermal equivalent and the air exposure in this 3-dimensional *in vitro* model ([@bib35]). For establishment of OTCs, hiPSCs were transfected with *HIPK4* siRNA, cultured for 4 or 10 days under differentiation conditions, and seeded on scaffold-based dermal equivalents. While a 10-day predifferentiation hampered successful growth in OTCs (data not shown), predifferentiation of 4 days allowed for a sufficient number of cells to attach and grow in OTCs for 3 more weeks ([Figure 5](#fig5){ref-type="fig"}A). OTCs were analyzed for epithelial markers by immunohistochemistry. In the *siControl* condition, cells demonstrate organoid structures of mixed populations of mesenchymal cells and K8/K18-positive epithelial cells. In contrast, cells transduced with *HIPK4* siRNA showed an improved differentiation in early epithelium ([Figures 5](#fig5){ref-type="fig"}B and [S5](#mmc1){ref-type="supplementary-material"}). The laminin staining indicates the basement membrane zone, on top of which epidermal cells should stratify. In the *siControl* condition, very few cells were stained for K8 or K18 because this differentiation time point was too early to generate epidermal progenitors. In the *siHIPK4* condition, however, we observed a thicker basal layer with basal cell stratification, on top of which lay a monolayer of K8- and K18-positive cells. Moreover, the analysis of later epidermal keratins such as K10 and K14 showed almost no staining in the *siControl* condition but strong staining in the basal layer under *HIPK4* knockdown, suggesting that these keratins were already expressed at this time of differentiation and that a proper basal layer was formed ([Figure 5](#fig5){ref-type="fig"}C). Interestingly, the quantification of positive cells for early keratins (K8, K18, K19) and late keratins (K14, K10) showed an increase of all keratin expression whenever *HIPK4* was silenced compared with the control condition ([Figure 5](#fig5){ref-type="fig"}C).Figure 5HIPK4 Silencing Promotes the Differentiation of Epithelial Precursors in Organotypic Cultures(A) Schematic overview of the organotypic culture (OTC) protocol. hiPSC D1 were differentiated for 4 days and included in a 3D co-culture with human dermal fibroblasts for 3 weeks.(B) Immunostaining against Laminin β1 and K8, K18, K10, and K14 in paraffin sections of 3-week-old OTCs from either HIPK4 siRNA (*siHIPK4*) or a non-targeting siRNA (*siControl*) transfected cells. Scale bar, 100 μm.(C) Graph showing quantification of keratin-positive cells as a percentage of the total epithelial cells. Antibodies against K14, K10, K19, K8, and K18 were used. Data represent the mean of three independent experiments ± SEM. Statistical analysis was performed using unpaired Student\'s t test (^∗^p \< 0.05, ^∗∗∗^p \< 0.001).

Discussion {#sec3}
==========

In this work, we have identified HIPK4 as a key inhibitor of human skin epithelial differentiation by performing a high-throughput RNAi screening analysis during this process and by monitoring the number of K18^+^ cells. K18 is a classical marker of simple epithelia during early embryonic development, which includes ectodermal epithelium ([@bib4]). Nevertheless, the results presented here showed an upregulation of ectodermal/skin epithelial markers and no expression of endodermal, mesodermal, or neuroectodermal markers at day 10 of differentiation. These data strongly suggest that K18^+^ cells monitored in the screen were mainly skin epithelial cells. Interestingly, several members of the MAPK signaling pathway were found among the screen\'s candidates. This signaling pathway plays a central role in keratinocyte differentiation, since *Map2k1*/*Map2k2* (*Mek1*/*Mek2*) double-knockout mice die 24 hr postnatally, due to dehydration and loss of barrier function of the skin ([@bib31]). Also, MAPKAPK2 and 3 (mitogen-activated protein kinase-activated protein kinase 2 and 3) are kinases which are regulated by the FGFR signaling pathway ([@bib37]).

HIPK4 regulation has not been extensively studied to date. It was described to phosphorylate p53 at Ser9 and to be structurally related to HIPK1--3 for its catalytic domain ([@bib2]). Although *Hipk1*/*2* double-knockout mice die in utero, suggesting overlapping functions for these two family members ([@bib17]), no *Hipk4* knockout mouse has been deeply investigated. Based on the transcriptome analysis of the knockdown cells, we suggest that HIPK4 could influence several signaling pathways such as Wnt/β-catenin, NF-κB, PTEN, IL-6, and TGF-β/BMP. Wnt/β-catenin signaling is an important regulator during skin development and, in particular, catenins play a key role in epidermal development ([@bib3], [@bib29]). Interestingly, NF-κB signaling, which was predicted to be inactivated in our analysis, can induce epithelial cell growth arrest ([@bib32], [@bib33]). PTEN signaling is involved in epithelial migration, proliferation, and morphogenesis ([@bib7], [@bib12]). Although IL-6 signaling (and its downstream target *STAT3*) was recently shown to be involved in lung epithelial development, its role in skin epithelial development is yet to be clarified ([@bib20]). Of note, IL-6 can increase the phosphorylation of K18 in epithelial cells ([@bib39]). Lastly, TGF-β/BMP signaling is known to be important in early development and particularly in epidermal differentiation ([@bib9], [@bib23], [@bib24], [@bib28]). More recently, inhibition of TGF-β signaling by a small compound was suggested to improve keratinocyte differentiation from hiPSCs ([@bib34]).

In conclusion, after validation of a kinome RNAi screen, we demonstrated that loss of *HIPK4* expression improves early skin epithelial differentiation accompanied by an increase in K8 and K18 expression, and improves late keratinocyte differentiation with an increase of epidermal identity (K5/K14/p63). Additionally we found that *HIPK4* knockdown favors the epithelial differentiation in an organotypic culture, with an enhanced basal layer formation and an increased expression of several keratins, including late epidermal keratins such as K14 and K10. Therefore we propose that HIPK4 acts as a control mechanism of epithelial/epidermal differentiation by preventing excessive K18^+^ precursor differentiation. This mechanism involving HIPK4 kinase activity and phosphorylation of its downstream targets should be examined more closely. This mechanism may also involve the activation of IL-6 and/or TGF-β signaling pathways. Taken together, these data present microscopy RNAi screens as a powerful tool to reveal novel regulators of human skin epithelial differentiation, and therefore will help to improve the current differentiation protocols from PSCs.

Experimental Procedures {#sec4}
=======================

Generation of hiPSCs {#sec4.1}
--------------------

Human iPSC D1 and HD1 lines were generated from fibroblasts of healthy donors (University Medical Center Mannheim, Germany; ethics committee approval no. 2009-350N-MA) as previously described ([@bib22]). In brief, human fibroblasts were infected with lentiviral particles carrying an inducible polycistronic cassette containing the reprogramming factors *OCT4*, *SOX2*, *KLF4*, and *c-MYC*. Generated iPSCs were maintained in culture on Matrigel in mTeSR medium (Invitrogen Life Technologies, Darmstadt, Germany).

Differentiation of hiPSCs into Skin Epithelial Cells {#sec4.2}
----------------------------------------------------

For skin epithelial differentiation, the protocol was adapted from [@bib18]. Cells were trypsinized and seeded at single-cell level in DKSFM containing 1 μM all-*trans* RA, 10 ng/mL BMP4, and 50 μg/mL Normocin. The next day, medium was changed to fresh DKSFM containing RA and BMP4. On day 4, cells were washed twice with DMEM/F12 and fresh DKSFM supplemented with 50 μg/mL Normocin. The differentiation was stopped at different time points for RNA or protein isolation.

High-Throughput RNAi Screen {#sec4.3}
---------------------------

siRNAs (siGenome, Dharmacon) were prealiquoted in Matrigel-precoated 384-well plates to a final concentration of 250 nM using an automated workstation (Biomek FX, Beckman Coulter). hiPSCs were reverse transfected using Lipofectamine RNAiMAX Transfection Reagent (Life Technologies). After trypsinization, cells were seeded either with a cytokine-containing DKSFM (for differentiation) or with mTeSR (for pluripotency maintenance). The plates were shortly spun down and kept at 37°C and 5% CO~2~. On culture day 5 an additional 50 μL of DKSFM without additional cytokines was added. The cells were cultured until day 10. Fixation (4% paraformaldehyde), blocking (3% BSA and 0.05% Triton X-100), and fluorescence staining were performed using an automated workstation. The K18 primary antibody dilution was 1:25. The plates were sealed and incubated over night at 4°C. Next day the cells were washed three times with PBS and incubated for 1 hr with the secondary antibody (anti-mouse Atto 594) together with Hoechst. After washing, the plates were sealed and stored at 4°C until imaging. The high-throughput screen was performed using a human RNAi library (siGenome, Dharmacon) consisting of a pool of four siRNAs per gene, targeting kinases, and kinase-regulatory proteins.

Image Analysis of Screen Data {#sec4.4}
-----------------------------

Imaging was performed using an automated BD Pathway 855 Bioimaging System (Becton Dickinson) with a 20× objective (numerical aperture 0.75) and a Hamamatsu digital camera (Orca-ER). Per well, 25 fields were imaged for both filters, Hoechst (nuclei staining) and Atto 594 (K18 staining). Images were analyzed using the Cellprofiler image analysis software Version 2.0. Object selection was based on adaptive intensity and fixed-size thresholds for each individual object. The segmentation of objects was optimized in order to reach the best resolution even in dense cell clusters. For data analysis, parent objects were segmented in channel 1 (Hoechst), and in channel 2 (Atto 594) the mean intensity of child objects was measured. Based on the mean intensity of every nucleus, nuclei were categorized into a K18^+^ and K18^−^ cell, according to the manually set mean intensity threshold. The values of K18^+^ cells were used for further analysis. To prevent strong viability effects, we excluded wells with less than 1,000 cells from the analysis. For data analysis, cellHTS2 software was used. The fraction of K18^+^ cells per well was normalized per assay plate and the *Z* scores were calculated using the R package cellHTS2. The correlation between the data of replicates was estimated using the Spearman rank correlation coefficient. Inhibitor hit: *Z* score \< positive control; promoter hit: *Z* score \> 2.

Gene Expression and Ingenuity Analyses {#sec4.5}
--------------------------------------

Illumina gene expression raw data from biological triplicates of NHK, D1 hiPSC (day 0), day-5, day-10, day-30 differentiated cells, and their counterpart with silenced *HIPK4* were normalized in CHIPSTER software. Unsupervised hierarchical clustering was performed after filtering genes with a variance test (p \< 0.05). Differential gene expression between day-10 *siHIPK4* sample and day-10 *siControl* sample was determined using an empirical Bayes statistical test. Gene signatures for ectodermal development or epithelial and epidermal differentiation were downloaded from the GO database (GO:0030856, GO:0072148). Gene signatures for pluripotency, or endodermal, mesodermal, and neuroectodermal development were downloaded from the GO database or from published transcriptome profiling (GO:0019827) ([@bib36]).

Regulated genes (n = 391) in day-10 *siHIPK4* sample were then uploaded to IPA (Ingenuity Pathway Analysis) software to evaluate the most regulated signaling pathways. All raw data have been uploaded on the public database under accession GEO: [GSE102067](ncbi-geo:GSE102067){#intref0015}.

siRNA Transfection {#sec4.6}
------------------

The cells were transfected 1 day after seeding and differentiated for 10 days. Transfection reagent (Lipofectamine RNAiMAX) was added to DMEM/F12 and incubated for 10 min. After incubation time, either the set of four siRNAs against *HIPK4* or the non-targeting *siControl* were added and incubated for 20 min at room temperature. The transfection mix was then added to the cells with a final siRNA concentration of 25 nM. After 2 days, medium was aspirated, the cells were washed twice with PBS, and cytokine-containing DKSFM was added. At day 4 of differentiation the medium was aspirated, and the cells washed again and cultured in DKSFM without cytokines. The medium was changed every 2 days. siRNA sequences were: *HIPK4* J-004808-09 AGU AUA UGC UCA AGU CGU U; *HIPK4* J-004808-10 AGA CGA AGG UGC GCC CAU U; *HIPK4* J-004808-11 AGA AGG AGG CUG CGG GUA U; *HIPK4* J-004808-12 GCA ACA ACG AGU ACG ACC A; Non-targeting Pool \#2 (1) UAA GGC UAU GAA GAG AUA C; Non-targeting Pool \#2 (2) AUG UAU UGG CCU GUA UUA G; Non-targeting Pool \#2 (3) AUG AAC GUG AAU UGC UCA A; Non-targeting Pool \#2 (4) UGG UUU ACA UGU CGA CUA A.

Overexpression {#sec4.7}
--------------

Human iPSCs were transduced with a lentiviral expression vector (pTriEx-1) coding for wild-type *HIPK4* (WT HIPK4 OE), kinase dead mutant *HIPK4* (mutant HPIK4), or with the empty vector (vector) as a control, and differentiated for 10 days.

Immunofluorescence {#sec4.8}
------------------

Cells grown on coverslips were washed twice with PBS, fixed with 4% paraformaldehyde in PBS for 30 min, and treated with blocking buffer (3% BSA, 0.1% Triton X-100 in 1× PBS) for 45 min. Antibody dilution (500 μL) was added per coverslip and incubated overnight at 4°C. Primary antibodies included keratin-14 (Covance), keratin-18 (Progen), and p63 (Abcam). Quantification of positive cells was calculated after counting a minimum of 300 cells per conditions.

Western Blot and qPCR {#sec4.9}
---------------------

Whole-cell extracts representative of three independent experiments were prepared from hiPSCs, NHK isolated from biopsies of healthy donors (University Medical Center Manheim, Germany), or differentiated cells at different time points. Primary antibodies used were K18 (Progen, \#11,416), HIPK4 (Acris, \#AP52050PU-N), and α-actinin (Santa Cruz Biotechnology, \#sc-17829). RNA from hiPSCs, NHK, or from day-5, day-10, and day-30 differentiated cells was extracted using an RNeasy kit (QIAGEN). Real-time qPCR was performed using the SYBR Green Supermix (Applied Biosystems) on a 7500 Real-Time PCR system (Applied Biosystems). Primers used for qPCR were as follows: *18S*, 5′-GAG GAT GAG GTG GAA CGT GT-3′ (forward \[fwd\]) and 5′-TCT TCA GTC GCT CCA GGT CT-3′ (reverse \[rev\]); *GAPDH*, 5′-GAA GGT GAA GGT CGG AGT C-3′ (fwd) and 5′-GAA GAT GGT GAT GGG ATT TC-3′ (rev); *K14*, 5′-AGG AGA TCG CCA CCT ACC GCC-3′ (fwd) and 5′-AGG AGG TCA CAT CTC TGG ATG ACT G-3′ (rev); *K18*, 5′-GAG TAT GAG GCC CTG CTG AAC ATC A-3′ (fwd) and 5′-GCG GGT GGT GGT CTT TTG GAT-3′ (rev); *K5*, 5′-ATC TCT GAG ATG AAC CGG ATG ATC-3′ (fwd) and 5′-CAG ATT GGC GCA CTG TTT CTT-3′ (rev); *K8*, 5′-GAT CGC CAC CTA CAG GAA GCT-3′ (fwd) and 5′-ACT CAT GTT CTG CAT CCC AGA CT-3′ (rev); *p63*, 5′-TTC TTA GCG AGG TTG GGC TG-3′ (fwd) and 5′-GAT CGC ATG TCG AAA TTG CTC-3′ (rev), Involucrin, 5′-CTC CAT GTG TCA TGG GAT ATG-3′ (fwd) and 5′-TCA ACC TGA AAG ACA GAA GAG-3′ (rev). Expression values were normalized to housekeeping genes *18S* or *GAPDH*.

Organotypic Culture and Immunohistochemistry {#sec4.10}
--------------------------------------------

The dermal equivalents were made in membrane insert-containing 6-well plates and comprised a circular piece of non-woven scaffold (22 mm), 750 μL of thrombin (10 U/mL) mixed with human dermal fibroblasts in fetal bovine serum (FBS), and 750 μL of fibrinogen (8 mg/mL). Thrombin and fibroblasts were soaked into the dry scaffold before the fibrinogen solution was added carefully and gently mixed. After combining the components, a soft fibrin clot formed in about 10 min at 37°C, which was then immersed in DMEM with 10% FBS containing 50 μg of L-ascorbic acid (sigma) and 1 ng/mL TGFB1 (R&D Systems). Precultivation was performed for 2--5 days with medium change every other day. The day before the epithelial cells were seeded, the dermal equivalents were shifted to rFAD medium (three-fourths DMEM and one-fourth Ham\'s F12 supplemented with 10% FBS, 10^−10^ M cholera toxin, 0.4 mg of hydrocortisone, and 50 mg/mL L-ascorbic acid) mixed with DKSFM (1:1) to equilibrate them for the co-culture phase. In the organotypic co-cultures, the DKSFM was changed every other day during a period of 3 weeks. Specimens of OTCs were then embedded in Tissue Tek (Miles, Elkhart, IN, USA) and frozen in liquid nitrogen vapor. Cryostat sections (6 μm) were mounted on 3-aminopropyl-triethoxysilane-coated slides and air dried. The sections were fixed in 80% methanol at 4°C for 5 min followed by absolute acetone at −20°C for 2 min and preblocked with 3% BSA in PBS. The incubation with the primary antibody was carried out in a moist chamber either overnight at 4°C or at 37°C for 1 hr followed by 30 min at room temperature. Laminin antibody was gift from Prof. J.M. Foidart, University of Liege, Belgium. Reference numbers of other antibodies: Keratin 14 (BioLegend Inc., \#905301), Keratin 10 (Progen, DE-K10, \#11414), Keratin 8 (Progen, clone Ks 8.7, \#61038), Keratin 18 (Progen, Ks 18.04, \#61028), Keratin 19 (Progen, \#GP-CK19). Secondary antibodies were applied together with 2 μg/mL DAPI for nuclear staining for 30 min at 37°C followed by 30 min at room temperature in a moist chamber. After washing thoroughly, the sections were mounted in Fluorescent Mounting Medium (Dako) and stored in the dark at 4°C. The specimens were examined with a Leica DMRBE/RD photomicroscope equipped with epifluorescence illumination, and micrographs were recorded with a CCD camera (F-View 12) applying Analysis Pro 6.0 software (Olympus Soft Imaging Solutions, Munster, Germany).
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